ZHYBF — Zhong Yuan Bio-Technology Holdings Share Price
Last trade - 00:00- $88.40m
- $89.84m
- $1.66m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 349.14 | ||
| Price to Tang. Book | 349.14 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 35.45 | ||
| EV to EBITDA | 394.16 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 25.61% | ||
| Return on Equity | 64.23% | ||
| Operating Margin | 9.14% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1.22 | 1.22 | 1.64 | 2.33 | 1.66 | n/a | n/a | 8.1% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Zhong Yuan Bio-Technology Holdings Ltd is an investment holding company principally engaged in the development and sale of health supplements. The Company operates its business through two segments. The Sales of Health Care Supplements segment is engaged in the development and sale of new drugs for neurological disorders, brain disease detection kits, the sale of plant-derived nervonic acid health supplements as well as others. The Company's main products are nervonic acid series supplements, marketed under the 'Muzhiyuan Neuro Enhancer' brand. The Technical Supporting Services segment is engaged in the provision of technical services.
Directors
- Last Annual
- March 31st, 2023
- Last Interim
- September 30th, 2023
- Incorporated
- August 21st, 2018
- Public Since
- March 5th, 2021
- No. of Employees
- 35
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 17,679,618
- Address
- Suite 901, BEVERLY HILLS, 00000
- Web
- Phone
- +852 null29198916
- Auditors
- Centurion ZD CPA & Co
Upcoming Events for ZHYBF
Similar to ZHYBF
Acacia Diversified Holdings
Pink Sheets on Nasdaq
Acusphere
Pink Sheets on Nasdaq
Adorbs
Pink Sheets on Nasdaq
Agentix
Pink Sheets on Nasdaq
Agrios Global Holdings
Pink Sheets on Nasdaq
FAQ
As of Today at 19:24 UTC, shares in Zhong Yuan Bio-Technology Holdings are trading at $5.00. This share price information is delayed by 15 minutes.
Shares in Zhong Yuan Bio-Technology Holdings last closed at $5.00 and the price had moved by over the past 365 days. In terms of relative price strength the Zhong Yuan Bio-Technology Holdings share price has underperformed the S&P500 Index by -13.63% over the past year.
There is no consensus recommendation for this security.
Zhong Yuan Bio-Technology Holdings does not currently pay a dividend.
Zhong Yuan Bio-Technology Holdings does not currently pay a dividend.
Zhong Yuan Bio-Technology Holdings does not currently pay a dividend.
To buy shares in Zhong Yuan Bio-Technology Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $5.00, shares in Zhong Yuan Bio-Technology Holdings had a market capitalisation of $88.40m.
Here are the trading details for Zhong Yuan Bio-Technology Holdings:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: ZHYBF
Based on an overall assessment of its quality, value and momentum Zhong Yuan Bio-Technology Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zhong Yuan Bio-Technology Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -13.08%.
As of the last closing price of $5.00, shares in Zhong Yuan Bio-Technology Holdings were trading +24.03% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Zhong Yuan Bio-Technology Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $5.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Zhong Yuan Bio-Technology Holdings' directors